0000000000001685

AUTHOR

Hiroyuki Shimada

showing 1 related works from this author

Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma P…

2012

Background Of 4,706 peripheral neuroblastic tumors (pNTs) registered on the Children’s Cancer Group and Children’s Oncology Group Neuroblastoma Study between 1989 and 2010, 51 cases (1.1%) had genotype-phenotype discordance characterized by MYCN amplification (indicating poor prognosis) and Favorable Histology (indicating better prognosis).

OncologyPathologymedicine.medical_specialtybusiness.industryCancerHematologymedicine.diseaseNeuroblastic TumorN-Myc Proto-Oncogene ProteinGenotype phenotypePeripheralOncologyNeuroblastomaInternal medicinePediatrics Perinatology and Child HealthMycn amplificationMedicineImmunohistochemistrybusinessneoplasmsPediatric Blood & Cancer
researchProduct